Alan A Martin (Alan Martin)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Robyn Kendall, Alan A Martin, Dhvani Shah, Soham Shukla, Chris Compton, Afisi S Ismaila
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK. International journal of chronic obstructive pulmonary disease 18 (2023)
David M G Halpin, Robyn Kendall, Soham Shukla, Alan A Martin, Dhvani Shah, Dawn Midwinter, Kai-Michael Beeh, Janwillem W H Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough, Afisi S Ismaila
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Andrea Gabrio, Necdet B Gunsoy, Gianluca Baio, Alan A Martin, Victoria Federico Paly, Nancy Risebrough, David M G Halpin, Dave Singh, Robert A Wise, MeiLan K Han, Fernando J Martinez, Gerard J Criner, Neil Martin, David A Lipson, Afisi S Ismaila
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Soham Shukla, Dhvani Shah, Alan A Martin, Nancy A Risebrough, Robyn Kendall, Claus F Vogelmeier, Isabelle H Boucot, Lee Tombs, Bjermer Leif, Paul W Jones, Edward M Kerwin, Chris Compton, Francois Maltais, David A Lipson, Afisi S Ismaila
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. International journal of chronic obstructive pulmonary disease 16 (2021)
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan A Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta, Afisi S Ismaila
Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International journal of chronic obstructive pulmonary disease 15 (2020)
Afisi S Ismaila, Nancy Risebrough, Melanie Schroeder, Dhvani Shah, Alan A Martin, Emma C Goodall, Kerigo Ndirangu, Gerard Criner, Mark Dransfield, David Mg Halpin, MeiLan K Han, David A Lomas
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial. International journal of chronic obstructive pulmonary disease 14 (2019)